Bulletin
Investor Alert

Seattle Genetics Inc.

NAS: SGEN

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Dec 13, 2019, 5:10 p.m.

/zigman2/quotes/203326163/composite

$

113.87

Change

0.00 0.00%

Volume

Volume 100,099

Quotes are delayed by 20 min

/zigman2/quotes/203326163/composite

Previous close

$ 112.26

$ 113.87

Change

+1.61 +1.43%

Day low

Day high

$111.68

$114.86

Open

52 week low

52 week high

$51.50

$122.36

Open

Annual Financials for Seattle Genetics Inc.

Fiscal year is January-December. All values USD millions. 20142015201620172018 5-year trend
Sales/Revenue 286.76M336.8M418.15M482.25M654.7M
Cost of Goods Sold (COGS) incl. D&A 29.06M37.44M42.32M54.12M88.29M
COGS excluding D&A 16.57M22.94M24.28M29.85M62.26M
Depreciation & Amortization Expense 12.49M14.51M18.03M24.27M26.03M
Depreciation 11.69M13.7M17.23M23.47M25.33M
Amortization of Intangibles 800,000805,000800,000800,000700,000
Gross Income 257.7M299.36M375.83M428.13M566.41M
20142015201620172018 5-year trend
SG&A Expense 335.06M420.31M518.56M623.93M826.41M
Research & Development 230.74M294.53M379.31M456.7M565.31M
Other SG&A 104.32M125.78M139.25M167.23M261.1M
Other Operating Expense -----
Unusual Expense ---(33.78M)(7.34M)
EBIT after Unusual Expense ---(162.02M)(252.66M)
Non Operating Income/Expense -----
Non-Operating Interest Income 1.22M464,0002.61M3.14M6.32M
Equity in Affiliates (Pretax) -----
Interest Expense -----
Gross Interest Expense -----
Interest Capitalized -----
Pretax Income (76.14M)(120.49M)(140.11M)(158.89M)(246.35M)
Income Tax ---(33.36M)(23.65M)
Income Tax - Current Domestic -----
Income Tax - Current Foreign -----
Income Tax - Deferred Domestic -----
Income Tax - Deferred Foreign -----
Income Tax Credits -----
Equity in Affiliates -----
Other After Tax Income (Expense) -----
Consolidated Net Income (76.14M)(120.49M)(140.11M)(125.53M)(222.69M)
Minority Interest Expense -----
Net Income (76.14M)(120.49M)(140.11M)(125.53M)(222.69M)
Extraordinaries & Discontinued Operations -----
Extra Items & Gain/Loss Sale Of Assets -----
Cumulative Effect - Accounting Chg -----
Discontinued Operations -----
Net Income After Extraordinaries (76.14M)(120.49M)(140.11M)(125.53M)(222.69M)
Preferred Dividends -----
Net Income Available to Common (76.14M)(120.49M)(140.11M)(125.53M)(222.69M)
EPS (Basic) (0.62)(0.93)(1.00)(0.88)(1.41)
Basic Shares Outstanding 123.41M129.18M140.75M143.17M157.66M
EPS (Diluted) (0.62)(0.93)(1.00)(0.88)(1.41)
Diluted Shares Outstanding 123.41M129.18M140.75M143.17M157.66M
EBITDA (64.87M)(106.45M)(124.69M)(171.53M)(233.97M)
Link to MarketWatch's Slice.